Evogene (XTAE:EVGN) Other Operating Expense : ₪1.92 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Evogene Other Operating Expense?

Evogene's Other Operating Expense for the three months ended in Mar. 2024 was ₪1.92 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₪1.92 Mil.

Evogene's quarterly Other Operating Expense increased from Sep. 2023 (₪0.00 Mil) to Dec. 2023 (₪0.00 Mil) and increased from Dec. 2023 (₪0.00 Mil) to Mar. 2024 (₪1.92 Mil).

Evogene's annual Other Operating Expense declined from Dec. 2021 (₪-0.00 Mil) to Dec. 2022 (₪-12.97 Mil) but then increased from Dec. 2022 (₪-12.97 Mil) to Dec. 2023 (₪0.00 Mil).

Evogene Other Operating Expense Historical Data

The historical data trend for Evogene's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evogene Other Operating Expense Chart

Evogene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-12.97

Evogene Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	1.92

Evogene Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪1.92 Mil.

Evogene Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Evogene's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Evogene (XTAE:EVGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evogene Ltd (XTAE:EVGN) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

EVGN:USA

Address

13 Gad Feinstein Street, Park Rehovot, P.O. Box 4173, Ness Ziona, Rehovot, ISR, 7414002

Website

https://www.evogene.com

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.